L-Marc Research Center   Report issue

Academic/Hospital Phase 2 Phase 4
Founded: Louisville KY United States (1986)

Organization Overview

First Clinical Trial
2007
NCT00409305
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2014

Timeline

NOW
  • Now

Alternative names

L-MARC Research Center | Louisville Metabolic and Atherosclerosis Research Center

Active Ingredients

Drugs in Phase 4 Trials (3)

cholestyramine (questran) (2 trials)

colesevelam (welchol) (1 trial)

tang (1 trial)

Drugs in Phase 2 Trials (3)

betahistine (1 trial)

diazoxide choline (1 trial)

sitagliptin (januvia) (2 trials)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Body Weight (Phase 2)

Diabetes Mellitus (Phase 2)

Diabetes Mellitus, Type 2 (Phase 2)

Hypertriglyceridemia (Phase 2)

Renal Insufficiency (Phase 2)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 6
  • # of Trial APIs: 6